Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...

Seaport will use the funds for its neuropsychiatric drug pipeline, while Hemab will focus on bleeding disorder medicines.

CPC Biotech, part of PSG and Dover (NYSE: DOV) and a leading manufacturer of connectors, pumps, and flow sensors used in biopharmaceutical processing, today announced the launch of the AseptiQuik® G ...

Fifth-grade students at Helmsburg Elementary are getting a hands-on look at science through a series of biotech labs that ...

One CEO said people should be using AI to understand their health much more than they already do.

The pharma royalty funding market hit a record $10 billion in 2025. A single AI experiment that improved a cancer drug in ...

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) ranks among the most profitable biotech stocks to buy now. Following comments on ...

CLEVELAND, Ohio— The Cleveland biotech start-up Asclepii, founded in a college dorm room, is seeking to change lives for ...

Explore India's biopharma potential as it addresses supply chain challenges and fosters innovation in biotechnology and ...

Telix Pharmaceuticals Ltd (ASX:TLX) has delivered a sharp reminder of how quickly sentiment can swing in biotech — with a blockbuster partnership sending shares surging earlier this week, only for a ...

See more on Vaxcyte's (PCVX) and VAX-31’s broad pneumococcal vaccine pipeline, strong cash runway, and key 2026–2027 trial ...